ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

Includes May issue of Business & Regulatory Report.

May 31, 2002

Program Announcements, RFA In Radiation Effects Available

September 24, 1982

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

‘Helping Smokers Quit’ Program Launched By NCI, Pharmacist Group

June 27, 1986

Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI

August 27, 2010

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997